Englitazone
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by DMacks (talk | contribs) at 04:05, 22 June 2020 (Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 04:05, 22 June 2020 by DMacks (talk | contribs) (Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB))
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C20H19NO3S |
Molar mass | 353.44 g·mol−1 |
3D model (JSmol) | |
|
Englitazone is a hypoglycemic agent of thiazolidinedione (glitazone) class.
See also
- Ciglitazone
- Darglitazone
- Netoglitazone
- Troglitazone
- Rivoglitazone—currently in clinical trials
- Pioglitazone, lobeglitazone, rosiglitazone—the only ones currently in clinical use
References
PPARαTooltip Peroxisome proliferator-activated receptor alpha |
|
---|---|
PPARδTooltip Peroxisome proliferator-activated receptor delta | |
PPARγTooltip Peroxisome proliferator-activated receptor gamma |
|
Non-selective | |
|